Feener Edward P. has filed 40 insider transactions across 1 company since January 2023.
Most recent transaction: a option exercise of 18789 shares of KalVista Pharmaceuticals, Inc. ($KALV) on May 17, 2024.
Activity breakdown: 0 open-market purchases and 12 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 18789 | $0.00 | 80,946.0000 | 36,786,575 | 30.23% | 0.05% |
| May 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 8088 | $11.76 | 72,858.0000 | 36,786,575 | 9.99% | 0.02% |
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 14,190.0000 | 36,786,575 | 11.11% | 0.00% |
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Unit | 2431 | $0.00 | 14,583.0000 | 36,786,575 | 14.29% | 0.01% |
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Performance Stock Units | 7292 | $0.00 | 0.0000 | 36,786,575 | 100.00% | 0.02% |
| May 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Performance Stock Units | 7292 | $0.00 | 14,583.0000 | 36,786,575 | 33.33% | 0.02% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 18788 | $0.00 | 90,445.0000 | 0 | 26.22% | 0.00% |
| Feb. 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 8397 | $14.11 | 82,048.0000 | 0 | 9.28% | 0.00% |
| Feb. 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 19591 | $14.04 | 62,457.0000 | 0 | 23.88% | 0.00% |
| Feb. 20, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 300 | $14.72 | 62,157.0000 | 0 | 0.48% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Unit | 1774 | $0.00 | 15,964.0000 | 0 | 10.00% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Unit | 2430 | $0.00 | 17,014.0000 | 0 | 12.50% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Performance Stock Units | 7292 | $0.00 | 7,292.0000 | 0 | 50.00% | 0.00% |
| Feb. 17, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | M | Performance Stock Units | 7292 | $0.00 | 21,875.0000 | 0 | 25.00% | 0.00% |
| Feb. 14, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | S | Common Stock | 28171 | $15.01 | 71,657.0000 | 0 | 28.22% | 0.00% |
| Feb. 11, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | A | Common Stock | 60000 | $0.00 | 99,828.0000 | 0 | 150.65% | 0.00% |
| Feb. 11, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | CHIEF SCIENTIFIC OFFICER | A | Performance Stock Units | 29167 | $0.00 | 29,167.0000 | 0 | 9999.99% | 0.00% |
| Jan. 11, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 22679 | $13.03 | 39,828.0000 | 0 | 36.28% | 0.00% |
| Jan. 8, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 17221 | $13.01 | 62,607.0000 | 0 | 21.57% | 0.00% |
| Jan. 9, 2024 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 100 | $13.00 | 62,507.0000 | 0 | 0.16% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Common Stock | 11497 | $0.00 | 84,786.0000 | 0 | 15.69% | 0.00% |
| Nov. 20, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 4958 | $8.23 | 79,828.0000 | 0 | 5.85% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 1774 | $0.00 | 17,738.0000 | 0 | 9.09% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 2431 | $0.00 | 19,444.0000 | 0 | 11.11% | 0.00% |
| Nov. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Performance Stock Unit | 7292 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 1773 | $0.00 | 19,512.0000 | 0 | 8.33% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Common Stock | 11494 | $0.00 | 78,265.0000 | 0 | 17.21% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 2430 | $0.00 | 21,875.0000 | 0 | 10.00% | 0.00% |
| Aug. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Performance Stock Unit | 7291 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Aug. 18, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 4976 | $10.73 | 73,289.0000 | 0 | 6.36% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 2430 | $0.00 | 26,736.0000 | 0 | 8.33% | 0.00% |
| Jan. 11, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | A | Restricted Stock Unit | 29166 | $0.00 | 29,166.0000 | 0 | 9999.99% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Common Stock | 4205 | $0.00 | 68,557.0000 | 0 | 6.53% | 0.00% |
| May 18, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 1786 | $10.14 | 66,771.0000 | 0 | 2.61% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 2431 | $0.00 | 24,305.0000 | 0 | 9.09% | 0.00% |
| May 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 1774 | $0.00 | 21,285.0000 | 0 | 7.69% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Common Stock | 4204 | $0.00 | 66,580.0000 | 0 | 6.74% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | S | Common Stock | 2228 | $7.66 | 64,352.0000 | 0 | 3.35% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Performance Restricted Stock Unit | 2430 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 17, 2023 | KalVista Pharmaceuticals, Inc. | $KALV | Feener Edward P. | Chief Scientific Officer | M | Restricted Stock Unit | 1774 | $0.00 | 23,059.0000 | 0 | 7.14% | 0.00% |